Industry News
Long-lasting infection-control solution now available in Australia
SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices. [ + ]
Vaccine rollout may face delays
Insufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world. [ + ]
New evidence that scalp cooling protects hair from chemotherapy
Groundbreaking UK research has provided biological evidence that scalp cooling physically protects hair follicles from chemotherapy drugs. [ + ]
WHO invites Health Literacy Initiative to join global network
The Mental Health Commission of NSW will join the World Health Organization (WHO) in a global network to improve community health literacy. [ + ]
Facebook issues update on COVID-19 misinformation
Facebook has announced important updates to its misinformation policy in relation to COVID-19, COVID-19 vaccines and vaccines in general during the pandemic. [ + ]
Register now for Australian Healthcare Week 2021
The 2021 Australian Healthcare Week Expo will feature six free-to-attend on-floor programs designed for all areas of the healthcare community. [ + ]
Breakthrough surgical robotic system breaks out in Australia
Macquarie University Hospital is reported to be the first facility in Australia to adopt breakthrough, minimally invasive robotic surgical technology. [ + ]
Osteoporosis Australia rebrands as Healthy Bones Australia
Osteoporosis Australia has announced an official rebrand and the launch of an educational resource hub to reinforce the importance of fracture prevention. [ + ]
Russian Sputnik vaccine demonstrates 91.6% efficacy
Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19. [ + ]
Aus biotech company supplies at-home COVID-19 tests to US
Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests. [ + ]
Medical Training Survey reveals culture needs addressing
According to more than 21,000 doctors in training, the quality of their training is generally high, but concerns persist regarding the culture of medicine. [ + ]
Blood cancer burden on the rise
Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation. [ + ]
Novavax vaccine demonstrates 89.3% efficacy
Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK. [ + ]
Day hospital group acquires majority stake in private hospital development
Cura Day Hospitals Group has acquired a majority stake in Somerset Private Hospital, which will provide locals with world-class health care close to home. [ + ]
ANPC develops new COVID-19-detecting technology
A patent has been filed for advanced magnetic resonance technology that can detect the pathological signature of COVID-19 without relying on direct detection of the SARS-CoV-2 virus. [ + ]
